FDA approves weight-loss drug Zepbound to treat sleep apnea - The Washington Post
- FDA approves weight-loss drug Zepbound to treat sleep apnea The Washington Post
- F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The New York Times
- FDA Approves First Medication for Obstructive Sleep Apnea FDA.gov
- FDA approves weight-loss drug Zepbound for obstructive sleep apnea CNN
- FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity Investors | Eli Lilly and Company